Utah Medical Products, Inc.
UTMD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $9,812 | $9,953 | $9,710 | $9,158 |
| % Growth | -1.4% | 2.5% | 6% | – |
| Cost of Goods Sold | $4,752 | $4,897 | $4,172 | $3,835 |
| Gross Profit | $5,060 | $5,056 | $5,538 | $5,323 |
| % Margin | 51.6% | 50.8% | 57% | 58.1% |
| R&D Expenses | $167 | $135 | $155 | $121 |
| G&A Expenses | $0 | $0 | $915 | $5,696 |
| SG&A Expenses | $2,282 | $1,725 | $1,415 | $7,597 |
| Sales & Mktg Exp. | $0 | $0 | $500 | $1,901 |
| Other Operating Expenses | $0 | $0 | $815 | -$5,325 |
| Operating Expenses | $2,449 | $1,860 | $2,385 | $2,393 |
| Operating Income | $2,611 | $3,196 | $3,153 | $2,930 |
| % Margin | 26.6% | 32.1% | 32.5% | 32% |
| Other Income/Exp. Net | $698 | $639 | $705 | $684 |
| Pre-Tax Income | $3,309 | $3,835 | $3,858 | $3,614 |
| Tax Expense | $678 | $787 | $817 | $712 |
| Net Income | $2,631 | $3,048 | $3,041 | $2,902 |
| % Margin | 26.8% | 30.6% | 31.3% | 31.7% |
| EPS | 0.79 | 0.92 | 0.92 | 0.86 |
| % Growth | -14.1% | 0% | 7% | – |
| EPS Diluted | 0.82 | 0.94 | 0.92 | 0.86 |
| Weighted Avg Shares Out | 3,310 | 3,310 | 3,310 | 3,388 |
| Weighted Avg Shares Out Dil | 3,207 | 3,246 | 3,310 | 3,388 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $753 | $745 | $721 | $717 |
| EBITDA | $4,062 | $4,581 | $4,188 | $3,984 |
| % Margin | 41.4% | 46% | 43.1% | 43.5% |